Shareholder Information

Angel Pharmaceuticals is a clinical-stage biotech company dedicated to developing a robust pipeline of innovative medicines for cancer and autoimmune diseases.

The company was launched in strategic collaboration with U.S.-based Corvus Pharmaceuticals, Inc., with investments from Puissance Capital, Hisun Pharmaceuticals, Tigermed, and funds affiliated with Betta Pharmaceuticals.